Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Silencing of the Mutant Huntingtin Gene through CRISPR-Cas9 Improves the Mitochondrial Biomarkers in an In Vitro Model of Huntington's Disease.

Dunbar GL, Koneru S, Kolli N, Sandstrom M, Maiti P, Rossignol J.

Cell Transplant. 2019 Apr 4:963689719840662. doi: 10.1177/0963689719840662. [Epub ahead of print]

PMID:
30947515
2.

CRISPR-Cas9 Mediated Gene-Silencing of the Mutant Huntingtin Gene in an In Vitro Model of Huntington's Disease.

Kolli N, Lu M, Maiti P, Rossignol J, Dunbar GL.

Int J Mol Sci. 2017 Apr 2;18(4). pii: E754. doi: 10.3390/ijms18040754.

3.

[Research progress of CRISPR-Cas9 system for gene therapy].

Zhan C, Xia X.

Sheng Wu Gong Cheng Xue Bao. 2016 Jul 25;32(7):861-869. doi: 10.13345/j.cjb.150542. Review. Chinese.

4.

[Advances in application of clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated 9 system in stem cells research].

Sun SJ, Huo JH, Geng ZJ, Sun XY, Fu XB.

Zhonghua Shao Shang Za Zhi. 2018 Apr 20;34(4):253-256. doi: 10.3760/cma.j.issn.1009-2587.2018.04.013. Review. Chinese.

PMID:
29690746
5.

Hot News: Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.

Soriano V.

AIDS Rev. 2017 Oct-Dec;19(3):167-172.

PMID:
29019352
6.

CRISPR-Cas9: A New Addition to the Drug Metabolism and Disposition Tool Box.

Karlgren M, Simoff I, Keiser M, Oswald S, Artursson P.

Drug Metab Dispos. 2018 Nov;46(11):1776-1786. doi: 10.1124/dmd.118.082842. Epub 2018 Aug 20. Review.

PMID:
30126863
7.

Postnatal Cardiac Gene Editing Using CRISPR/Cas9 With AAV9-Mediated Delivery of Short Guide RNAs Results in Mosaic Gene Disruption.

Johansen AK, Molenaar B, Versteeg D, Leitoguinho AR, Demkes C, Spanjaard B, de Ruiter H, Akbari Moqadam F, Kooijman L, Zentilin L, Giacca M, van Rooij E.

Circ Res. 2017 Oct 27;121(10):1168-1181. doi: 10.1161/CIRCRESAHA.116.310370. Epub 2017 Aug 29.

PMID:
28851809
8.

CRISPR/Cas9 Editing of the Mutant Huntingtin Allele In Vitro and In Vivo.

Monteys AM, Ebanks SA, Keiser MS, Davidson BL.

Mol Ther. 2017 Jan 4;25(1):12-23. doi: 10.1016/j.ymthe.2016.11.010. Epub 2017 Jan 4.

9.

Bacterial CRISPR/Cas DNA endonucleases: A revolutionary technology that could dramatically impact viral research and treatment.

Kennedy EM, Cullen BR.

Virology. 2015 May;479-480:213-20. doi: 10.1016/j.virol.2015.02.024. Epub 2015 Mar 7. Review.

10.

Genome engineering through CRISPR/Cas9 technology in the human germline and pluripotent stem cells.

Vassena R, Heindryckx B, Peco R, Pennings G, Raya A, Sermon K, Veiga A.

Hum Reprod Update. 2016 Jun;22(4):411-9. doi: 10.1093/humupd/dmw005. Epub 2016 Feb 29. Review.

PMID:
26932460
11.

Delivering CRISPR: a review of the challenges and approaches.

Lino CA, Harper JC, Carney JP, Timlin JA.

Drug Deliv. 2018 Nov;25(1):1234-1257. doi: 10.1080/10717544.2018.1474964. Review.

12.

[The application of CRISPR-Cas9 gene editing technology in viral infection diseases].

Yin LJ, Hu SQ, Guo F.

Yi Chuan. 2015 May;37(5):412-8. doi: 10.16288/j.yczz.14-460. Review. Chinese.

PMID:
25998428
13.

Establishment of a highly efficient virus-inducible CRISPR/Cas9 system in insect cells.

Dong ZQ, Chen TT, Zhang J, Hu N, Cao MY, Dong FF, Jiang YM, Chen P, Lu C, Pan MH.

Antiviral Res. 2016 Jun;130:50-7. doi: 10.1016/j.antiviral.2016.03.009. Epub 2016 Mar 12.

PMID:
26979473
14.

CRISPR-Cas9 technology and its application in haematological disorders.

Zhang H, McCarty N.

Br J Haematol. 2016 Oct;175(2):208-225. doi: 10.1111/bjh.14297. Epub 2016 Sep 13. Review.

15.

CRISPR/Cas9 technology as a potent molecular tool for gene therapy.

Karimian A, Azizian K, Parsian H, Rafieian S, Shafiei-Irannejad V, Kheyrollah M, Yousefi M, Majidinia M, Yousefi B.

J Cell Physiol. 2019 Jan 30. doi: 10.1002/jcp.27972. [Epub ahead of print] Review.

PMID:
30697727
16.

Cutting Edge Genetics: CRISPR/Cas9 Editing of Plant Genomes.

Soyars CL, Peterson BA, Burr CA, Nimchuk ZL.

Plant Cell Physiol. 2018 Aug 1;59(8):1608-1620. doi: 10.1093/pcp/pcy079.

PMID:
29912402
17.

CRISPR/Cas9 for genome editing: progress, implications and challenges.

Zhang F, Wen Y, Guo X.

Hum Mol Genet. 2014 Sep 15;23(R1):R40-6. doi: 10.1093/hmg/ddu125. Epub 2014 Mar 20. Review.

PMID:
24651067
18.

Recent advances in CRISPR/Cas9 mediated genome editing in Bacillus subtilis.

Hong KQ, Liu DY, Chen T, Wang ZW.

World J Microbiol Biotechnol. 2018 Sep 29;34(10):153. doi: 10.1007/s11274-018-2537-1. Review.

PMID:
30269229
19.

Genome modification by CRISPR/Cas9.

Ma Y, Zhang L, Huang X.

FEBS J. 2014 Dec;281(23):5186-93. doi: 10.1111/febs.13110. Epub 2014 Nov 7. Review.

20.

[Application of clustered regularly interspaced short palindromic repeats- associated protein 9 gene editing technology for treatment of HBV infection].

Wang YD, Liang QF, Li ZY, Zhao CY.

Zhonghua Gan Zang Bing Za Zhi. 2018 Nov 20;26(11):860-864. doi: 10.3760/cma.j.issn.1007-3418.2018.11.012. Chinese.

PMID:
30616324

Supplemental Content

Support Center